ADAM8 antibody (AA 677-824)

Catalog No. ABIN7150062

The Rabbit Polyclonal anti-ADAM8 antibody has been validated for WB, ELISA, IHC and IF. It is suitable to detect ADAM8 in samples from Human.

Quick Overview for ADAM8 antibody (AA 677-824) (ABIN7150062)

Target: ADAM8 (ADAM Metallopeptidase Domain 8 (ADAM8))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ADAM8 antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Product Details anti-ADAM8 Antibody

Binding Specificity: AA 677-824

Cross-Reactivity: Human, Mouse

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Disintegrin and metalloproteinase domain-containing protein 8 protein (677-824AA)

Isotype: IgG

Application Details

Application Notes: Recommended dilution: WB:1:500-1:5000, IHC:1:200-1:500, IF:1:50-1:200,

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for ADAM8

Target: ADAM8 (ADAM Metallopeptidase Domain 8 (ADAM8))

Alternative Name: ADAM8

Background:

Background: Possible involvement in extravasation of leukocytes.

Aliases: A Disintegrin And Metalloproteinase domain 8 antibody, ADAM 8 antibody, ADAM 8 precursor antibody, ADAM metallopeptidase domain 8 antibody, Adam8 antibody, ADAM8 protein antibody, ADAM8_HUMAN antibody, CD 156 antibody, CD156 antibody, CD156a antibody, CD156a antigen antibody, Cell surface antigen MS2 antibody, Disintegrin and metalloproteinase domain-containing protein 8 antibody, Human leukocyte differentiation antigen antibody, Macrophage cysteine rich glycoprotein antibody, MGC134985 antibody, MS 2 antibody, MS2 antibody

UniProt: P78325

Pathways: Activation of Innate immune Response, M Phase